Compare Stocks: SNOA, AYTU, UPC, and ABVC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABVC ABVC BioPharma	$0.96 -4.0%	$1.17	$0.71 ▼ $3.40	$25.59M	0.61	105,290 shs	142,449 shs
AYTU Aytu BioPharma	$2.21 -3.5%	$2.24	$1.65 ▼ $3.07	$23.71M	0.26	49,341 shs	15,883 shs
SNOA Sonoma Pharmaceuticals	$1.33 +0.4%	$1.25	$0.85 ▼ $4.74	$6.34M	1.31	132,447 shs	92,753 shs
UPC Universe Pharmaceuticals	$4.03 -6.9%	$5.20	$2.00 ▼ $17.96	$20.23M	1.58	815,759 shs	68,272 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABVC ABVC BioPharma	+15.67%	+25.68%	-6.54%	-24.81%	-63.10%
AYTU Aytu BioPharma	+0.44%	+2.23%	+3.62%	+1.78%	-2.14%
SNOA Sonoma Pharmaceuticals	+2.33%	-0.75%	+10.00%	+15.79%	-71.37%
UPC Universe Pharmaceuticals	-9.22%	-14.09%	-38.58%	+32.42%	+15.47%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABVC ABVC BioPharma	$0.96 -4.0%	$1.17	$0.71 ▼ $3.40	$25.59M	0.61	105,290 shs	142,449 shs
AYTU Aytu BioPharma	$2.21 -3.5%	$2.24	$1.65 ▼ $3.07	$23.71M	0.26	49,341 shs	15,883 shs
SNOA Sonoma Pharmaceuticals	$1.33 +0.4%	$1.25	$0.85 ▼ $4.74	$6.34M	1.31	132,447 shs	92,753 shs
UPC Universe Pharmaceuticals	$4.03 -6.9%	$5.20	$2.00 ▼ $17.96	$20.23M	1.58	815,759 shs	68,272 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABVC ABVC BioPharma	+15.67%	+25.68%	-6.54%	-24.81%	-63.10%
AYTU Aytu BioPharma	+0.44%	+2.23%	+3.62%	+1.78%	-2.14%
SNOA Sonoma Pharmaceuticals	+2.33%	-0.75%	+10.00%	+15.79%	-71.37%
UPC Universe Pharmaceuticals	-9.22%	-14.09%	-38.58%	+32.42%	+15.47%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABVC ABVC BioPharma	1.00	Sell	N/A	N/A
AYTU Aytu BioPharma	2.25	Hold	$10.75	380.98% Upside
SNOA Sonoma Pharmaceuticals	1.00	Sell	N/A	N/A
UPC Universe Pharmaceuticals	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SNOA, AYTU, UPC, and ABVC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2026	SNOA Sonoma Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/13/2026	AYTU Aytu BioPharma	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/7/2026	SNOA Sonoma Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/29/2026	UPC Universe Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/24/2026	SNOA Sonoma Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/15/2026	AYTU Aytu BioPharma	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
7/14/2026	UPC Universe Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/6/2026	AYTU Aytu BioPharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/29/2026	UPC Universe Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/15/2026	ABVC ABVC BioPharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/11/2026	AYTU Aytu BioPharma	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$14.00 ➝ $14.50

(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABVC ABVC BioPharma	$510K	48.23	N/A	N/A	$0.46 per share	2.01
AYTU Aytu BioPharma	$66.38M	0.36	$0.37 per share	6.07	$2.11 per share	1.06
SNOA Sonoma Pharmaceuticals	$21.92M	0.29	N/A	N/A	$1.38 per share	0.95
UPC Universe Pharmaceuticals	$17.86M	1.17	N/A	N/A	$99.64 per share	0.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABVC ABVC BioPharma	-$7.91M	-$0.30	N/A	N/A	N/A	N/A	-47.68%	-30.97%	11/16/2026 (Estimated)
AYTU Aytu BioPharma	-$13.56M	-$4.58	N/A	8.94	N/A	-60.17%	-69.93%	-13.25%	9/29/2026 (Estimated)
SNOA Sonoma Pharmaceuticals	-$3.17M	-$1.22	N/A	N/A	N/A	-10.33%	-21.41%	-6.08%	11/16/2026 (Estimated)
UPC Universe Pharmaceuticals	-$3.67M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest SNOA, AYTU, UPC, and ABVC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/29/2026	Q4 2026	AYTU Aytu BioPharma	-$0.29	N/A	N/A	N/A	$12.28 million	N/A
8/12/2026	Q2 2026	ABVC ABVC BioPharma	-$0.40	-$0.03	+$0.37	-$0.03	$0.11 million	N/A
8/6/2026	Q1 2027	SNOA Sonoma Pharmaceuticals	-$0.30	$0.02	+$0.32	-$0.09	$4.99 million	$6.41 million
7/29/2026	Q2 2026	UPC Universe Pharmaceuticals	N/A	-$1.38	N/A	-$1.38	N/A	$4.52 million
6/16/2026	Q4 2026	SNOA Sonoma Pharmaceuticals	-$0.24	-$0.33	-$0.09	-$0.33	$5.57 million	$5.56 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABVC ABVC BioPharma	N/A	N/A	N/A	N/A	N/A
AYTU Aytu BioPharma	N/A	N/A	N/A	N/A	N/A
SNOA Sonoma Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
UPC Universe Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABVC ABVC BioPharma	N/A	0.07	0.07
AYTU Aytu BioPharma	0.27	1.12	1.00
SNOA Sonoma Pharmaceuticals	N/A	2.99	2.29
UPC Universe Pharmaceuticals	0.04	4.05	3.90

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABVC ABVC BioPharma	11.38%
AYTU Aytu BioPharma	33.49%
SNOA Sonoma Pharmaceuticals	1.95%
UPC Universe Pharmaceuticals	0.18%

Insider Ownership

Company	Insider Ownership
ABVC ABVC BioPharma	19.00%
AYTU Aytu BioPharma	4.90%
SNOA Sonoma Pharmaceuticals	1.02%
UPC Universe Pharmaceuticals	57.38%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABVC ABVC BioPharma	30	26.65 million	21.59 million	Not Optionable
AYTU Aytu BioPharma	160	10.73 million	10.21 million	Not Optionable
SNOA Sonoma Pharmaceuticals	180	4.79 million	4.74 million	Not Optionable
UPC Universe Pharmaceuticals	220	5.02 million	2.14 million	N/A

SNOA, AYTU, UPC, and ABVC Headlines

Recent News About These Companies

Universe Pharmaceuticals shares rise 22.6% premarket with no new catalyst identified

September 2 at 8:38 AM | msn.com

Universe Pharmaceuticals (UPC) stock soars over 38% after-hours: Here's what's going on

September 2 at 8:38 AM | msn.com

Universe Pharmaceuticals (NASDAQ:UPC) Upgraded at Wall Street Zen

August 29, 2026 | americanbankingnews.com

Universe Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:UPC

July 18, 2026 | benzinga.com

Universe Pharmaceuticals INC - Ordinary Shares - Class A

July 17, 2026 | money.usnews.com

Universe Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:UPC | Benzinga

June 29, 2026 | benzinga.com

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

June 29, 2026 | markets.businessinsider.com

China's Universe Pharmaceuticals (NASDAQ: UPC) Makes Nasdaq Top Gainer List on Acquisition News

June 29, 2026 | investorideas.comI

Universe Pharmaceuticals INC.: Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

June 27, 2026 | finanznachrichten.de

Universe Pharmaceuticals Inc

June 26, 2026 | fool.com

UPC stock surges 288% after hours — what’s driving the rally?

June 26, 2026 | msn.com

Universe Pharmaceuticals to acquire Best Praise for $10.75M

June 26, 2026 | seekingalpha.com

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

June 26, 2026 | globenewswire.com

Universe Pharmaceuticals Stock News

June 17, 2026 | benzinga.com

Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology

June 16, 2026 | businesswire.com

Universe Pharmaceuticals Incorporation Class A

April 29, 2026 | edition.cnn.com

Universe Pharmaceuticals (NASDAQ:UPC) Stock Price Down 2.4% â€“ Time to Sell?

April 25, 2026 | defenseworld.netD

Universe Pharmaceuticals Sets February 13 Effective Date for Dual-Class Share Structure

February 11, 2026 | tipranks.com

Universe Pharmaceuticals INC Implements Dual-Class Share Structure on Nasdaq Effective February 13, 2026

February 11, 2026 | quiverquant.comQ

Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure

February 11, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SNOA, AYTU, UPC, and ABVC Company Descriptions

ABVC BioPharma NASDAQ:ABVC

$0.96 -0.04 (-3.99%)

As of 04:00 PM Eastern

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.

Aytu BioPharma NASDAQ:AYTU

$2.21 -0.08 (-3.49%)

As of 04:00 PM Eastern

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Sonoma Pharmaceuticals NASDAQ:SNOA

$1.32 +0.01 (+0.38%)

As of 04:00 PM Eastern

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Gramaderm for the treatment of topical mild to moderate acne; Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens; Ocucyn eyelid and eyelash cleanser; Microdacyn60 oral care solution for the treatment of mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; MicrocynVS, a veterinarian-strength animal care product used in vet clinics and animal hospitals; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.

Universe Pharmaceuticals NASDAQ:UPC

$4.03 -0.30 (-6.93%)

As of 04:00 PM Eastern

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SNOA, AYTU, UPC, and ABVC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SNOA, AYTU, UPC, and ABVC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SNOA, AYTU, UPC, and ABVC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SNOA, AYTU, UPC, and ABVC Company Descriptions

ABVC BioPharma NASDAQ:ABVC

Aytu BioPharma NASDAQ:AYTU

Sonoma Pharmaceuticals NASDAQ:SNOA

Universe Pharmaceuticals NASDAQ:UPC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SNOA, AYTU, UPC, and ABVC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SNOA, AYTU, UPC, and ABVC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SNOA, AYTU, UPC, and ABVC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SNOA, AYTU, UPC, and ABVC Company Descriptions

ABVC BioPharma NASDAQ:ABVC

Aytu BioPharma NASDAQ:AYTU

Sonoma Pharmaceuticals NASDAQ:SNOA

Universe Pharmaceuticals NASDAQ:UPC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools